Crossmark

The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective

Published Online: 2019-08-13

Published Print: 2019-10

Authors

Jeppesen, Palle Bekker
License Information

Text and Data Mining valid from 2019-08-13

Version of Record valid from 2019-08-13
More Information

Article History

First Online: 13 August 2019

Compliance with Ethical Standards

:

: P.B.J. has received grants/honoraria or consultation fees from: The Novo Nordisk Foundation, NPS Pharmaceuticals, Shire, Takeda, Ferring, GlyPharma, Therachon, VectiveBio, Naia Pharma, Albumedix, Baxter, Fresenius Kabi, ArTara Therapeutics.

Document is current